It is currently Mon Jul 27, 2015 6:40 pm
Carl Icahn raises the stakes for Big Pharma
The financier has set a high benchmark for bidders for the biotech firm. Fortune's John Simons explains why Big Pharma is likely to pay top dollar for a very risky asset.
Total posts 226632 • Total topics 23872 • Total members 15144